In conclusion, elevated serum IGF-1 levels can serve as a biomarker of poor ovarian response among poor responders. The LE pretreatment normalizes serum IGF-1 levels and may provide a benefit in gonadotropin and GnRH antagonist cycles. Hence, measurement of cycle day 2 IGF-1 serum levels may...